Key points from article :
Twin Health secured $50 million funding to advance its tech in reversing, improving, and preventing chronic metabolic diseases.
Its “Whole Body Digital Twin” tech uses AI to create models of individual metabolisms, leveraging data, clinical parameters, and self-reported preferences.
A mobile app provides personalized guidance in areas such as nutrition, sleep, activity and stress, in collab with a clinical care team.
Claims that it completed the world’s first randomized controlled trial (RCT) for reversing chronic metabolic disease.
There was a 2.9% reduction in HbA1c in the intervention group & significant elimination (94%) of type 2 diabetes medications.
“The funding will help... achieving lower costs, better outcomes and higher satisfaction,” - Jahangir Mohammed, CEO of Twin Health.
Findings published in the American Association of Clinical Endocrinology.
